Heparin immobilized on proteins usable for arterial prosthesis coating: Growth inhibition of smooth-muscle cells

Journal of Biomedical Materials Research

Volumn 39, Issue 3, 1998, Pages 446-452

  Laemmel, Eric ^a   Penhoat, Jacques ^a   Warocquier Clérout, Rita ^a   Sigot Luizard, Marie Françoise ^a  

^a UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

Author keywords

Albumin gelatin coating; Growth inhibition; Immobilized heparin; Smooth muscle cells; Vascular prosthesis

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADATION; CARDIOVASCULAR SYSTEM; CELLS; ENZYME IMMOBILIZATION; GROWTH KINETICS; MUSCLE; PHYSIOLOGICAL MODELS; PROTECTIVE COATINGS; PROTEINS;

ALBUMIN GELATIN COATINGS; ARTERIAL PROSTHESIS COATINGS; GROWTH INHIBITION; IMMOBILIZED HEPARIN; SMOOTH MUSCLE CELLS; VASCULAR PROSTHESIS;

BLOOD VESSEL PROSTHESES;

CYANAMIDE;

ANIMAL CELL; ARTERY DIAMETER; ARTERY PROSTHESIS; ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; BLOOD VESSEL GRAFT; BLOOD VESSEL PROSTHESIS; CELL PROLIFERATION; CROSS LINKING; GROWTH INHIBITION; IMMOBILIZED CELL; NONHUMAN; SMOOTH MUSCLE FIBER; THROMBOCYTE ACTIVATION; THROMBOGENICITY;

ALBUMINS; ANIMALS; BIOCOMPATIBLE MATERIALS; BLOOD VESSEL PROSTHESIS; CATTLE; CELL DIVISION; CROSS-LINKING REAGENTS; FIBRINOLYTIC AGENTS; GELATIN; HEPARIN; MATERIALS TESTING; MUSCLE DEVELOPMENT; MUSCLE, SMOOTH, VASCULAR; SURFACE PROPERTIES;

EID: 0032485320     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(19980305)39:3<446::AID-JBM14>3.0.CO;2-8     Document Type: Article

References (33)

1. L. de Cossart, T. V. How, and D. Annis, "A two year study of the performance of a small diameter polyurethane (Biomer®) arterial prosthesis," J. Cardiovasc. Surg., 30, 388-394 (1989).
2. S. P. Nikkari and A. W. Clowes, "Restenosis after vascular reconstitution," Ann. Med., 26, 95-100 (1994).
3. P. Pauletto, S. Sartore, and A. C. Pessina, "Smooth muscle cell proliferation and differentiation in neointima formation and vascular restenosis," Clin. Sci., 87, 467-479 (1994).
4. Y. Marois, N. Chakfé, X. Deng, M. Marois, T. How, M. W. King, and R. Guidoin, "Carbodiimide cross-linked gelatin: A new coating for porous polyester arterial prostheses," Biomaterials, 16, 1131-1139 (1995).
5. Y. Marois, N. Chakfé, R. Guidoin, R. C. Duhamel, R. Roy, M. Marois, M. W. King, and Y. Douville, "An albumin-coated polyester arterial graft: In vivo assessment of biocompatibility and healing characteristics," Biomaterials, 17, 3-14 (1996).
6. A. Albanese, R. Barbucci, J. Belleville, S. Bowry, R. Eloy, H. D. Lemke, and L. Sabatini, "In vitro biocompatibility evaluation of a heparinizable material (PUPA), based on polyurethane and poly(amido-amine) components," Biomaterials, 15, 129-136 (1994).
7. B. Seifert, T. Groth, K. Herrmann, and P. Romaniuk, "Immobilization of heparin on polylactide for application to degradable biomaterials in contact with blood," J. Biomater. Sci. Polym. Edn., 7, 277-287 (1995).
8. W. Marconi, A. Galloppa, A. Martinelli, and A. Piozzi, "New polyurethane compositions able to bind high amounts of both albumin and heparin: Part I," Biomaterials, 16, 449-456 (1995).
9. A. Gutowska, Y. H. Bae, H. Jacobs, F. Mohammad, D. Mix, J. Feijen, and S. W. Kim, "Heparin release from thermosensitive polymer coatings: In vivo studies," J. Biomed. Mater. Res., 29, 811-821 (1995).
10. D. K. Han, N. Y. Lee, K. D. Park, Y. H. Kim, H. I. Cho, and B. G. Min, "Heparin-like anticoagulant activity of sulphonated poly(ethylene oxide) and sulphonated poly(ethylene oxide)-grafted polyurethane," Biomaterials, 16, 467-471 (1995).
11. P. A. Hårdhammer, H. M. M. van Beusekom, H. U. Emanuelsson, S. H. Hofma, P. A. Albertsson, P. D. Verdouw, E. Boersma, P. W. Serruys, and W. J. van der Giessen, "Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries," Circulation, 93, 423-430 (1996).
12. L. A. Pukac, G. M. Hirsch, J. C. Lormeau, M. Petitou, J. Choay, and M. J. Karnovsky, "Antiproliferative effects of novel, nonanticoagulant heparin derivates on vascular smooth muscle cells in vitro and in vivo," Am. J. Pathol., 139, 1501-1509 (1991).
13. A. D. Snow, R. P. Bolender, T. N. Wight, and A. W. Clowes, "Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells," Am. J. Pathol., 137, 313-330 (1990).
14. K. Kodama, B. Pasche, P. Olsson, J. Swedenborg, L. Adolfsson, O. Larm, and J. Riesenfeld, "Antithrombin III binding to surface immobilized heparin and its relation to F Xa inhibition," Thromb. Haemost., 58, 1064-1067 (1987).
15. C. J. Van Delden, G. H. M. Engbers, and J. Feijen, "The effect of protein adsorption on the anticoagulant activity of surface immobilized heparin," J. Biomater. Sci. Polym. Edn., 7, 727-740 (1996).
16. R. Ross, "The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibres," J. Cell. Biol., 50, 172-186 (1971).
17. O. Skalli, P. Ropraz, A. Trzeciak, G. Benzonana, D. Gillessen, and G. Gabbiani, "A monoclonal antibody against a-smooth muscle actin: A new probe for smooth muscle differentiation," J. Cell. Biol., 103, 2787-2796 (1986).
18. J. Penhoat, M. F. Sigot-Luizard, and R. Warocquier-Clérout, "Prostacyclin secretion by human endothelial cell grown on carbodiimide cross-linked proteins: An assessment of the cytocompatibility of a substratum," Biomaterials, 14, 503-506 (1993).
19. P. K. Smith, A. K. Mallia, and G. T. Hermanson, "Colorimetric method for the assay of heparin content in immobilized heparin preparations," Anal. Biochem., 109, 466-473 (1980).
20. H. Al-Khaffaf and D. Charlesworth, "Albumin-coated vascular prostheses: A five-year follow-up," J. Vasc. Surg., 23, 686-690 (1996).
21. K. Kottke-Marchant, J. M. Anderson, Y. Umemura, and R. E. Marchant, "Effect of albumin-coating on the in vitro blood compatibility of Dacron arterial prostheses," Biomaterials, 10, 147-155 (1989).
22. W. M. Parkins, C. E. Koop, C. Riegel, H. M. Vars, and J. S. Lockwood, "Gelatin as a plasma substitute with particular reference to experimental haemorrhage and burn shock," Ann. Surg., 118, 193-214 (1943).
23. R. Warocquier-Clérout, Y. S. Lee, J. Penhoat, and M. F. Sigot-Luizard, "Comparative behaviour of L-929 fibroblastic and human endothelial cells onto crosslinked protein substrates," Cytotechnology, 3, 259-269 (1990).
24. C. J. Van Delden, G. H. M. Engbers, and J. Feijen, "Interaction of antithrombin III with surface-immobilized albumin-heparin conjugates," J. Biomed. Mater. Res., 29, 1317-1329 (1995).
25. D. Letourneur, B. L. Caleb, and J. J. Castellot, Jr., "Heparin binding, internalization and metabolism in vascular smooth muscle cells: I. Upregulation of heparin binding correlates with antiproliferative activity," J. Cell. Physiol., 165, 676-686 (1995).
26. I. Vlodavsky, H. Q. Miao, R. Atzmon, E. Levi, J. Zimmermann, R. Bar-Shavit, T. Peretz, and S. A. Ben-Sasson, "Control of cell proliferation by heparan sulfate and heparin-binding growth factors," Thromb. Haemost., 74, 534-540 (1995).
27. W. Völker, A. Böhm, A. Schmidt, C. M. Svahn, A. K. Gellerbring, C. Mattsson, S. Ekvärn, H. Robenek, and E. Buddecke, "Inhibition of smooth muscle cell proliferation and neointimal growth by low-anticoagulant heparin," Arzneim. Forsch. Drug Res., 45, 546-550 (1995).
28. J. J. Castellot, D. L. Beeker, R. D. Rosenberg, and M. J. Karnovsky, "Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells," J. Cell. Physiol., 120, 315-320 (1984).
29. S. S. Kang, C. Gosselin, D. Ren, and H. P. Greisler, "Selective stimulation of endothelial cell proliferation with inhibition of smooth muscle cell proliferation by fibroblast growth factor-1 plus heparin delivered from fibrin glue suspensions," Surgery, 118, 280-287 (1995).
30. C. J. Van Delden, G. H. M. Engbers, and J. Feijen, "The effect of protein adsorption on the anticoagulant activity of surface immobilized heparin," J. Biomater. Sci. Palym. Edn., 7, 727-740 (1996).
31. D. Letourneur, D. Logeart, T. Avramoglou, and J. Jozefonvicz, "Antiproliferative capacity of synthetic dextrans on smooth muscle cell growth: the model of derivatized dextrans as heparin-like polymers," J. Biomater. Sci. Polym. Edn., 4, 431-444 (1993).
32. G. B. Köveker, K. H. Petzke, M. Borg, and K. Nebendahl, "Reduction of thrombogenicity in small-diameter vascular prostheses seeded with autologous endothelial cells," Thorac. Cardiovasc. Surg., 34, 49-51 (1986).
33. L. A. Poole-Warren, K. Schindhelm, A. R. Graham, P. R. Slowiaczek, and K. R. Noble, "Performance of small diameter synthetic vascular prostheses with confluent autologous endothelial cell linings," J. Biomed. Mater. Res., 30, 221-229 (1996).